Chlamydia trachomatis RNA, TMA, Throat
Use
This is an in vitro nucleic acid amplification test (NAAT) utilizing transcription-mediated amplification (TMA) intended for qualitative detection of Chlamydia trachomatis ribosomal RNA from extragenital (throat) specimens. It is suitable for testing based on symptoms, sexual history, or known exposures at extragenital sites. Repeat testing of the same positive sample is generally not needed unless confirmatory testing is clinically warranted in low-prevalence settings or where positive predictive value is reduced. Confirmatory testing may target alternate nucleic acid regions using designated alternate target test codes. ([questdiagnostics.com](https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/faq/faq154?utm_source=openai))
Special Instructions
Not provided.
Limitations
Repeat testing of the same positive specimen using the same methodology is not recommended as it does not improve positive predictive value. Confirmatory testing using an alternate nucleic acid target should be considered only in rare cases where false-positive results could have significant consequences or in low-prevalence populations. ([questdiagnostics.com](https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/faq/faq154?utm_source=openai))
Methodology
Other
Biomarkers
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
Container
Aptima® Transport Tube
Collection Instructions
Throat (pharyngeal) swab placed in Aptima® Transport Tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 30 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant